Difference between revisions of "AM-1714"
From Wiki Weed
(Created page with "AM-1714 is a drug that acts as a reasonably selective agonist of the peripheral cannabinoid receptor CB2, with sub-nanomolar affinity and 490x selectivity over the rel...") |
|||
| Line 1: | Line 1: | ||
| − | AM-1714 is a drug that acts as a reasonably selective agonist of the peripheral [[cannabinoid receptor]] [[CB2]], with sub-nanomolar affinity and 490x selectivity over the related [[CB1]] receptor. In animal studies it has both analgesic and anti-allodynia effects. The 9-methoxy derivative | + | AM-1714 is a drug that acts as a reasonably selective agonist of the peripheral [[cannabinoid receptor]] [[CB2]], with sub-nanomolar affinity and 490x selectivity over the related [[CB1]] receptor. In animal studies it has both analgesic and anti-allodynia effects. The 9-methoxy derivative AM-1710 has similar CB2 affinity but only 54x selectivity over CB1. |
==See also== | ==See also== | ||
Latest revision as of 20:48, 16 February 2015
AM-1714 is a drug that acts as a reasonably selective agonist of the peripheral cannabinoid receptor CB2, with sub-nanomolar affinity and 490x selectivity over the related CB1 receptor. In animal studies it has both analgesic and anti-allodynia effects. The 9-methoxy derivative AM-1710 has similar CB2 affinity but only 54x selectivity over CB1.
